Skip to main content
TipRanks
Go Ultimate75% OFF

Merck KGaA (MER) AI Stock Analysis

4 Followers
CH:MER

Merck KGaA

(Six Swiss:MER)

Rating:―N/A
Action:N/A
Date:―

No summary available

Positive Factors
Diversified business modelExposure to three distinct science and technology markets diversifies the revenue base and reduces reliance on one product category. The recurring consumables and bioprocessing demand described in Life Science can provide a durable foundation alongside prescription medicines and electronic materials.
Negative Factors
Profitability deteriorationThe sustained decline in net and EBIT margins indicates that earnings conversion has weakened materially from prior levels. Even with a healthy gross margin, lower profitability reduces the cash and earnings benefit of each euro of revenue and can constrain reinvestment flexibility.

Merck KGaA (MER) vs. iShares MSCI Switzerland ETF (EWL)

-5%0%5%10%15%20%25%CH:MER0.00%EWL+11.55%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Market Cap
CHF 59.50B
Dividend Yield
1.99%
Average Volume (3M)
―
Price to Earnings (P/E)
33.1
Beta (1Y)
―
Revenue Growth
-0.61%
EPS Growth
-36.13%
Country
Switzerland
Employees
62,136
Sector
Healthcare
Sector Strength
51
Industry
Drug Manufacturers - Specialty & Generic

Merck KGaA Business Overview & Revenue Model

Company Description

Merck KGaA is a German science and technology company with operations divided into three core segments: Life Science, Healthcare, and Electronics. The Life Science division supplies essential tools, chemicals, and equipment to academic research insti...

Merck KGaA Peers Comparison

Overall Rating

UnderperformOutperform
Sector (51)

Financial Indicators

CH:MER against its peers
NameOverall RatingMarket CapP/E RatioROEDividend YieldRevenue GrowthEPS Growth
DE:SHLDE:SHL77OutperformEUR 48.89B21.7011.72%2.33%1.09%3.52%
DE:FREDE:FRE63NeutralEUR 28.87B18.357.83%2.04%6.52%35.52%
DE:SRTDE:SRT62NeutralEUR 18.47B70.897.81%0.33%4.19%63.32%
DE:DMPDE:DMP54NeutralEUR 1.66B13.0520.60%2.69%1.71%15.95%
Sector *51Neutral$7.86B-0.30-43.30%2.27%22.53%-2.21%
DE:EVTDE:EVT45NeutralEUR 485.01M-2.46-25.63%―-5.03%-13.63%

* Healthcare Sector Average

Performance Comparison

-50%-25%0%25%CH:MERDE:EVTDE:FREDE:SRTDE:DMPDE:SHLDec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
CH:MER and its peers over the selected period
Show on chartTickerCompany NamePriceChange% Change
CH:MERMerck KGaA100.000.000.00%
DE:EVTEvotec AG (UK)2.51-2.79-52.72%
DE:FREFresenius SE & Co. KGaA51.385.4611.89%
DE:SRTSartorius (0NIQ)224.0043.3824.02%
DE:DMPDermapharm Holding32.75-1.80-5.21%
DE:SHLSiemens Healthineers42.961.774.30%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.